MACRILEN
Drug
Strongbridge US INC.
Total Payments
$335,805
Transactions
894
Doctors
439
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $160,726 | 57 | 0 |
| 2018 | $175,080 | 837 | 439 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $160,726 | 57 | 47.9% |
| Honoraria | $116,250 | 34 | 34.6% |
| Travel and Lodging | $22,811 | 106 | 6.8% |
| Consulting Fee | $20,050 | 11 | 6.0% |
| Food and Beverage | $15,911 | 682 | 4.7% |
| Education | $57.96 | 4 | 0.0% |
Payments by Type
General
$175,080
837 transactions
Research
$160,726
57 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is (DETECT) | Novo Nordisk AS | $160,726 | 0 |
Top Doctors Receiving Payments for MACRILEN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boise, ID | $160,726 | 57 |
| , MD | Endocrinology, Diabetes & Metabolism | Sterling, VA | $17,216 | 22 |
| , M.D | Endocrinology, Diabetes & Metabolism | Austin, TX | $17,015 | 20 |
| , MBCHB, MD, FRCP(UK) | Endocrinology, Diabetes & Metabolism | Seattle, WA | $14,226 | 20 |
| , MD | Internal Medicine | Boston, MA | $13,080 | 29 |
| , M.D | Endocrinology, Diabetes & Metabolism | Phoenix, AZ | $12,963 | 19 |
| , MD, FACE | Endocrinology, Diabetes & Metabolism | Columbus, OH | $10,166 | 22 |
| , MD | Endocrinology, Diabetes & Metabolism | San Antonio, TX | $8,883 | 16 |
| , MD | Endocrinology, Diabetes & Metabolism | Jacksonville, FL | $6,606 | 12 |
| , M.D | Endocrinology, Diabetes & Metabolism | Miami, FL | $6,496 | 15 |
| , M.D | Endocrinology, Diabetes & Metabolism | Pittsburgh, PA | $6,350 | 13 |
| , MD | Endocrinology, Diabetes & Metabolism | Boston, MA | $6,287 | 12 |
| Tamara Wexler | Internal Medicine | New York, NY | $6,169 | 13 |
| , M.D | Endocrinology, Diabetes & Metabolism | Ann Arbor, MI | $5,356 | 8 |
| , M.D | Endocrinology, Diabetes & Metabolism | Springfield, MA | $5,251 | 9 |
| , M.D | Endocrinology, Diabetes & Metabolism | West Valley City, UT | $5,211 | 9 |
| , MD | Endocrinology, Diabetes & Metabolism | Biloxi, MS | $5,176 | 11 |
| , M.D | Endocrinology, Diabetes & Metabolism | New York, NY | $4,988 | 11 |
| , MD | Internal Medicine | New York, NY | $4,837 | 8 |
| , M.D | Endocrinology, Diabetes & Metabolism | Plano, TX | $3,858 | 8 |
| , MD, PHD | Endocrinology, Diabetes & Metabolism | Seattle, WA | $1,326 | 10 |
| , M.D | Endocrinology, Diabetes & Metabolism | West Hollywood, CA | $1,019 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | New York, NY | $1,019 | 2 |
| , M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $918.56 | 2 |
| , MD | Endocrinology, Diabetes & Metabolism | Portland, OR | $918.56 | 2 |
Ad
Manufacturing Companies
- Strongbridge US INC. $175,080
- Novo Nordisk AS $160,726
Product Information
- Type Drug
- Total Payments $335,805
- Total Doctors 439
- Transactions 894
About MACRILEN
MACRILEN is a drug associated with $335,805 in payments to 439 healthcare providers, recorded across 894 transactions in the CMS Open Payments database. The primary manufacturer is Strongbridge US INC..
Payment data is available from 2018 to 2022. In 2022, $160,726 was paid across 57 transactions to 0 doctors.
The most common payment nature for MACRILEN is "Unspecified" ($160,726, 47.9% of total).
MACRILEN is associated with 1 research study, including "A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is (DETECT)" ($160,726).